1. Bcl-2 complexed with Beclin-1 maintains full anti-apoptotic function
- Author
-
Iwona A. Ciechomska, J N Skepper, G C Goemans, and Aviva M. Tolkovsky
- Subjects
Cancer Research ,Thapsigargin ,Immunoelectron microscopy ,Intracellular Space ,Apoptosis ,Biology ,Cycloheximide ,Mice ,chemistry.chemical_compound ,Genetics ,medicine ,Animals ,Humans ,Staurosporine ,Molecular Biology ,Cells, Cultured ,Endoplasmic reticulum ,Autophagy ,Membrane Proteins ,Tunicamycin ,Cell biology ,Gene Expression Regulation ,Proto-Oncogene Proteins c-bcl-2 ,chemistry ,Beclin-1 ,Apoptosis Regulatory Proteins ,Protein Binding ,medicine.drug - Abstract
The binding of Bcl-2 to Beclin-1 reduces Beclin-1's capacity to induce autophagy. Here, we have tested whether the interaction is reciprocated by loss of Bcl-2's anti-apoptotic function. We targeted Bcl-2 to mitochondria or endoplasmic reticulum (ER) and induced apoptosis using several apoptotic stimuli that initiate ER and/or mitochondrial signaling pathways (UV radiation, TNF and cycloheximide, staurosporine, thapsigargin and tunicamycin). When Beclin-1 and Bcl-2 were expressed together in HeLa cells, Beclin-1 (but not Beclin-1 lacking the Bcl-2-binding domain) followed Bcl-2 to the appropriate organelle with complete or near-complete overlap (comprising 60 and 30% of cells, respectively). The interaction between Beclin-1 and Bcl-2 was verified by immunoprecipitation, and a membrane-proximate localization of Beclin-1 was shown by immunoelectron microscopy. Apoptosis was followed by measuring changes in nuclear morphology, caspase-3 activity, poly-ADP-ribose polymerase cleavage or punctation of mRFP-Bax on mitochondria. Binding of Beclin-1 to Bcl-2 did not modify apoptosis irrespective of Bcl-2 concentration, location or apoptotic stimulus. A similar result was obtained in Atg5-/- cells that are autophagy-deficient, arguing against compensation for the loss of protection by Bcl-2 by autophagy-mediated survival induced by Beclin-1. Hence, although Beclin-1 contains a BH3-only motif typical of pro-apoptotic proteins, it is a negligible modulator of Bcl-2's anti-apoptotic function.
- Published
- 2009
- Full Text
- View/download PDF